Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy

British Journal of Ophthalmology

Volumn 97, Issue 8, 2013, Pages 1024-1031

  Punjabi, Omar S ^a   Huang, Joyce ^a   Rodriguez, Lina ^a   Lyon, Alice T ^a   Jampol, Lee M ^a   Mirza, Rukhsana G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; INDOCYANINE GREEN; RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; OCULAR HISTOPLASMOSIS; OPTICAL COHERENCE TOMOGRAPHY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

IMAGING; MACULA; RETINA;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84880008611     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303155     Document Type: Article

References (17)

1. Eye Diseases Prevalence Research Group. Prevalence of age related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72.
2. Sato T, Iida T, Hagimura N, et al. Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration. Retina 2004;24:910-14. (Pubitemid 39657488)
3. Poliner LS, Olk RJ, Burgess D, et al. Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 1986;93:543-51. (Pubitemid 16086703)
4. Gragoudas ES, Adamis AP, Cunningham ET, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16. (Pubitemid 40051904)
5. Axer-Siegel R, Ehrlich R, Rosenblatt I, et al. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 2004;122:453-9. (Pubitemid 38456279)
6. Nicolo M, Ghiglione D, Lai S, et al. Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to agerelated macular degeneration. Eur J Ophthalmol 2005;15:415-19. (Pubitemid 40943944)
7. Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina 2005;25:111-18. (Pubitemid 40365933)
8. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611. (Pubitemid 39099316)
9. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147:644-52.
10. Lumbroso B, Savastano MC, Rispoli M, et al. Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography. Retina 2011;31:553-8.
11. Chen E, Kaiser RS, Vander JF, et al. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration. Retina 2007;27:445-50. (Pubitemid 46624284)
12. Arora S, McKibbin M. One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration. Eye (Lond) 2011;25:1034-8.
13. Ach T, Hoeh AE, Ruppenstein M, et al. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Retina 2010;30:1420-5.
14. Chakravarthy U, Harding SP, Rogers CA, et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 2012;119:1399-411.
15. Clemens CR, Krohne TU, Charbel Issa P, et al. High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration. Br J Ophthalmol 2012;96:1088-91.
16. Penha FM, Rosenfeld PJ, Gregori G, et al. Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography. Am J Ophthalmol 2012;153:515-23.
17. Lee SY, Stetson PF, Ruiz-Garcia H, et al. Automated characterization of pigment epithelial detachment by OCT. Invest Ophthalmol Vis Sci 2012;53:164 -70.